Study Links Herpes Virus To Alzheimer's Risk, But Experts Urge Caution
A new study published in the scientific journal BMJ Open has found that herpes simplex virus type 1 (HSV-1), which causes cold sores, is associated with an increased risk of Alzheimer's disease.
However, experts emphasize that the findings show correlation, not causation, and more research is needed.
The study, conducted by researchers at Gilead Sciences Inc., analyzed health insurance data from 344,628 U.S. adults aged 50 and older diagnosed with Alzheimer's or related dementia between 2006 and 2021, each matched with a control of similar age, sex, and region without neurological disorders.
Of those with Alzheimer's, 0.44% had a prior HSV-1 diagnosis, compared to 0.24% of controls, suggesting an 80% higher relative risk for Alzheimer's among those with HSV-1. The absolute numbers, however, remain small. Additionally, individuals treated with antiviral medication for HSV-1 showed a 17% lower risk of developing Alzheimer's compared to untreated counterparts.
'Despite the large sample size, this research has limitations partly due to only using health records and administrative claims data,' said Dr. Sheona Scales, Director of Research at Alzheimer's Research UK, in a statement to the Science Media Centre. 'Most people infected with HSV-1 don't have any symptoms, so some infections might not have been recorded.'
Dr. David Vickers of the University of Calgary was more critical, stating, 'This pharma-funded research exaggerates the role of HSV-1, failing to appreciate its absence in 99.56 percent of [Alzheimer's disease] cases.'
The World Health Organization estimates two-thirds of people under 50 globally carry HSV-1, a neurotropic virus that can infect nerve cells and often lies dormant after initial infection, sometimes reactivating to cause cold sores.
Previous studies have detected HSV-1 DNA in postmortem Alzheimer's brains and shown it can trigger amyloid-beta plaque accumulation, a hallmark of the disease, in lab settings. A 2024 Journal of Virology study found HSV-1 can enter mouse brains, causing persistent inflammation, noting evidence for its role in Alzheimer's as 'overwhelming.'
'We're not saying viruses explain everything. But they may be central to it. This is no longer a fringe theory – it's the next phase of Alzheimer's research, and we're pursuing it,' Dr. Bryce Vissel of St. Vincent's Hospital Sydney told the Australian Science Media Centre.
However, Professor Tara Spires-Jones of the University of Edinburgh cautioned, 'It is important to note that HSV-1 infection, which is extremely common in the population, is by no means a guarantee that someone will develop Alzheimer's.'
The study's reliance on insurance data raises concerns, as HSV-1 is often underdiagnosed, potentially skewing results. It also lacks data on infection frequency or severity, which could influence risk.
'The study's data source makes its findings ungeneralisable, and it overstates a minor infection as a 'public health priority' to justify unnecessary treatment,' Vickers added.
Other factors, like genetics, lifestyle, or healthcare access, may also contribute to Alzheimer's risk among HSV-1 carriers.
Some experts see potential in antiviral treatments.
'With many GPs and the population being unaware of the dementia related benefits of treating HSV infections and preventing VZV activation through vaccination, it is time to call for actions informing those working in primary care as well as the population at large,' said Professor Cornelia van Duijn of the University of Oxford.
Dr. Richard Oakley of Alzheimer's Society advised, 'If you are worried about a cold sore or your general health, be sure to seek the appropriate help from a health professional.'
'More research is needed to understand the best way to protect our brains from Alzheimer's disease as we age,' Spires-Jones said. For now, experts recommend focusing on proven brain health strategies like exercise, sleep, and a balanced diet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
SLO's oldest home, La Loma Adobe, has a long, rich history that began in 1782
Adobe buildings are living structures. The adobe keeps strength by wicking moisture from the ground. Cut off from water, they crumble to dust. Too much water, and they melt. Sun-dried adobe bricks are formed from soil, sand and straw, and when well cared for, adobes are the oldest surviving buildings in California. Often the majority of the labor to create the bricks came from Native Americans, and adobe was the building material most available and affordable in the 1700s and early 1800s. The county has a mixed record of preserving adobe history. Mission San Luis Obispo has been restored from fire, Mission San Miguel from earthquake. Many others have suffered from neglect and melted in the rain. The city of San Luis Obispo owns three of these precious buildings. On May 29, 2005, reporter Leslie Griffy wrote a comprehensive story about their history and status. She quoted city engineer Mike McGuire, who said, 'These buildings were the homes of the founders of San Luis Obispo. ... They provide an important link to our past.' They were threatened then and unfortunately little has changed in 20 years. The exterior of the Rodriguez Adobe in the Arbors neighborhood was restored, but the interior is still rough. The Rosa Butrón de Canet Adobe on Dana Street needed serious work two decades ago after suffering damage from the San Simeon Earthquake. Recently a plan has been floated to build a tiny home village on the Dana Street property around the adobe, and that could be a funding driver to help restore the historic structure. Critics argue that the property was donated to the city to be preserved not developed. But time weighs heavily on unused buildings. The saddest story is of the oldest residence in the county. The two-story La Loma Adobe — also called the Bowden Adobe — is on Lizzie Street uphill from the San Luis Coastal Unified School District offices. The hillside home has been witness to weddings and dances, governors and generals. It was still an active residence as late as the mid-20th century. Now fenced off and fading, it was estimated in 2005 that La Loma needed as much as $2 million to be restored. Though some grants have been found for interim repairs, restoration remains elusive. In 1947 Telegram-Tribune reporter Cecilia Jensen wrote a series of stories about local historic adobes and landmarks as the state geared up for a centennial observance of the Gold Rush. This story about the La Loma Adobe was published on Dec. 10, 1947. On the brow of a hill at the end of Lizzie street, overlooking the city of San Luis Obispo, stands La Loma, believed to be the oldest adobe residence still standing in San Luis Obispo county. The most accurate records available indicate that the adobe was built in 1782, only 10 years after the Old Mission was established and in the year after George Washington accepted the surrender of Cornwallis to end the Revolutionary War. For the past 35 years the house has been occupied by the family of Mrs. Isabel Bowden. To the casual observer, it's ancient origin is not immediately apparent. A siding of lumber has been put over the adobe at some distant time and vines grow over much of the structure. Beneath this relatively modern exterior however, are the well preserved 'dobe walls, two feet thick and plastered white. What a story these old walls could tell. Knew Fremont Once the house quartered Gen. John C. Fremont during the winter encampment of 1846, when his battalion feasted on the cactus pears growing nearby in abundance. Its floors have also felt the steps of Pio Pico, last Mexican governor of Alta California; of Gen. Jose Castro, one of his predecessors; of Señorita Ramona Pacheco Wilson, mother of Romaldo Pacheco, governor of California in 1870, and her husband Captain John Wilson. District Judge Pablo De la Guerra of Santa Barbara, later a senator from that district, was among the prominent visitors at the adobe, which is believed to have been erected by Indian servants working under a Spanish landlord. Once the adobe was a trading post where furs and gold dust were bartered for supplies; again it was a tavern where infrequent travelers found food and lodging. Mexican grant Don Francisco Estevan Quintana was the first recorded owner of the property on which La Loma stands. He acquired La Vena rancho, comprising more than 6,000 acres in 1842 by a land grant from Gov. Manuel Micheltorena, next to the last of the Mexican governors of Alta California. In the same year, Señorita Mari Concepcion Boronda was granted the Potrero rancho of more than 3,500 acres, drained by Chorro creek. She traded part of Potrero rancho to Don Quintana for part of La Vena rancho including the site of La Loma. While Señorita Boronda was living in Monterey, which her family had helped to settle, she met Captain Oliver Deleissegus, a French reserve Navy captain. He had come to explore the Pacific coast, had been shipwrecked in Monterey Bay and had saved his life by swimming to shore. Oliver and 'Chonita' as she was reportedly nicknamed, fell in love, were married, and had five children before he died. The young widow then married Don Jose Maria Munoz, a native of Mexico, and a scholarly man. Early day judge Together they came to La Loma to live, where four children were born to them. Along with other enterprises, Munoz served as county judge for San Luis Obispo County for four years. To correct a flaw in the land title of Don Quintana, Judge Munoz homesteaded the quarter section surrounding La Loma and received a government patent from the United States on Sept. 15. 1870. Their children and Oliver's children grew up within the two-feet-thick white plastered walls, with their small windows and cool rooms. They climbed the outside stairway to the upstairs rooms, shaped exactly like the rooms beneath, where they slept. When they reached the proper age there were dances in the small ballroom upstairs. Romance flourished and beginning in 1871, Father Rouselle of the Old Mission began officiating in a series of weddings that took place in the almost century-old house. Here Miss Adela Deleissegues wed Michal Henderson, Miss Rebecca Haines became the bride of Albert Deleissegues; Miss Manuela Munoz married Fred Dana; Miss Carmen Hames plighted her troth to Guadalupe Munoz, who later moved to Ballard, Santa Barbara County; and Miss Eugino Durazo was married to Alexander Deleissegues. Another son, Ben Munoz, was a watchman for San Luis Obispo, and comprised the entire police department at that time. Judge Munoz was proud of his home and beautified the grounds with orange and fig trees and kept a wonderful garden. They looked down from their hillside vantage point onto the cotton field, which bordered their property, grown by Old Mission priests. Beyond was the olive orchard and the Old Mission itself. More houses were beginning to thicken the town. A new neighbor, Pierre Dallidet, had built an adobe down by the creek. In 1874 tragedy struck again in Maria Concepcion's life when Judge Munoz was drowned in a shipwreck while enroute to Mexico on a business trip. Her son, Alexander, assisted in operating the rancho. He subdivided the property, opened up Johnson Avenue and named Lizzie Street for a small niece of whom he was extremely fond. But widowed again, in 1887 Señora Maria Concepcion Boronda de Munoz sold the property to John Corbett of Corbett canyon, who was a great uncle to James J. Corbett, famous San Francisco boxer. On Sept. 22, 1898, the property passed to Caroline E. Noyes, who sold it to Charles Bowden on Feb. 24, 1914, his widow, Isabel, inheriting it on Sept. 5, 1930. In this tradition-drenched home that has seen more than a century of existence and still holds the atmosphere of its beginning, the Bowden family has grown up, still walking on floors in the upstairs rooms that were laid 165 years ago. The downstairs floors were packed dirt when the house was first erected.
Medscape
an hour ago
- Medscape
Real-World Cases of Skin Cancer Management in Older Adults
Supporting Data and the Patient's Response to Imiquimod Supporting that decision-making process was a randomized controlled trial published in 2017 comparing surgery with imiquimod 5% cream for nodular and superficial BCC, showing that imiquimod was inferior to surgery but still provided sustained benefit, Patel said. The 5-year success rates (absence of recurrence) in that trial were 82.5% compared with 97.7% for surgery (relative risk of imiquimod success, 0.84; 95% CI, 0.77-0.91; P < .001) — rates that were comparable to previously reported 3-year success rates of 83.6% and 98.4% for imiquimod and surgery, respectively. Most recurrences occurred within the first year. The 'caveat,' Patel said, was that the trial looked only at low-risk locations such as the cheek and the trunk, and not the tip of the nose. Patients with superficial BCC received 6 weeks of imiquimod cream once daily, and those with nodular BCC received 12 weeks. Use of this therapy 'requires clear explanation to the patient and an understanding of the off-label and not-fully-evaluated potential application,' Patel said in an interview after the meeting. After 6 weeks of treatment, the patient had notable crusting of the nasal tip with surrounding erythema. At 12 weeks, the tip of her nose was 'smooth with no obvious residual carcinoma notable,' Patal said at the meeting. 'She tolerated the treatment well and had a great response.' There have been suggestions made among some Mohs surgeons that the Mohs surgery AUC for primary superficial BCCs should be reevaluated, Patel said, referring to a Viewpoint piece published in JAMA Dermatology in July 2018 that pointed out that they are indolent, penetrate minimally, and are often multifocal, making them amenable to nonsurgical treatments. The lower-risk nodular BCC subtype is also worthy of AUC reevaluation, he said. Decision-Making About a Second Lesion: Melanoma In Situ (MIS) During the follow-up period, the patient's daughter noticed a large 2 cm pigmented area on her mother's wrist, and a biopsy revealed MIS. NCCN guidelines for MIS recommend surgical excision with margins of 0.5-1 cm but contain a footnote that consideration of topical immunotherapy or radiation therapy is an option in select patients with MIS of the lentigo maligna (LM) subtype, Patel said. He pointed to a retrospective review published 10 years ago looking at 63 MIS/LM cases in which imiquimod 5% cream was used as either primary or adjuvant therapy. When used as primary therapy, with no surgery, 72.7% demonstrated clinical clearance at a mean follow-up of 39.7 (range, 8-95) months. And when used as adjuvant therapy, 94.4% demonstrated clearance at a mean follow-up of 43.1 (range, 4-106) months. One could opt for primary therapy, knowing that 3 out of 4 patients might have clearance lasting over the course of several-plus years. Or, in the case of adjuvant therapy, 'you could do a partial resection or narrow margin resection, and if you have positive margins, go back and have an even higher success rate with adjuvant imiquimod cream,' Patel said. For his 88-year-old patient, 'surgery for a 2 cm tumor on the wrist, with skin that's fragile, is not easy to accomplish, certainly not easy to close up,' he said. The question was, 'could we cause more harm than good?' The patient decided on every-other-day treatment with 5% imiquimod cream for 6 weeks and responded with some clearing. She continued for another 6 weeks but on follow-up was noted to have some areas of progression. 'She ultimately needed an excision as the lesion was progressing in one area, and rebiopsy showed minimal invasion of the MIS, but she was now happy to do so as she felt it was necessary and declared by the disease,' Patel said after the meeting. She was able to undergo an excision with clear margins, and a complex layered closure with a partial skin graft was performed, which she tolerated well. A Patient With SCC In Situ (SCCis) Another patient recently referred to Patel for discussion of Mohs surgery was an 89-year-old man who had multiple rough, scaly patches on his bald scalp, a history of prostate cancer, hypertension managed with hydrochlorothiazide, and no family history of melanoma or keratinocyte carcinomas. Biopsies on two areas of the scalp vertex within 1 cm of each other and one on the neck revealed an SCC in situ on the scalp with an adjacent actinic keratosis (AK). In addition, a biopsy on the neck revealed 'AK with focal SCCis,' Patel said at the meeting. 'We'd agree this patient does not need Mohs. But [in this case] we posed a question that was [examined] in a recent study: Does SCC in situ need treatment at all?' Patel said, referring to a single-center cohort study published in 2024 in which 411 consecutive SCCis tumors with a clinically resolved biopsy site were managed with watchful waiting. Of the 411 tumors, 17 recurred locally (4% recurrence rate), and there were no instances of nodal metastases, distant metastases, or disease-specific death. The highest risk for local recurrence was conferred by a history of solid-organ transplantation (hazard ratio [HR], 9.979; 95% CI, 2.249-39.69), and additional risk factors predicting local recurrence were location of the tumor on the vermillion lip or ear (HR, 9.744; 95% CI, 1.420-69.28) and on the head and neck (HR, 6.687; 95% CI, 1.583-36.15). The size of the lesion was also predictive of recurrence, with biopsies showing tumor extension to the deep edge being associated with a sixfold increased risk (HR, 6.562; 95% CI, 1.367-39.04). 'In typical, run-of-the-mill smaller SCCis, the vast majority of these lesions after biopsy did not recur,' Patel said. Many experts have proposed the consideration of topical therapy as a first-line treatment for SCCis, but 'the question sometimes comes up of whether we can identify patients' at a higher risk for recurrence, he said. A study published this year of 5-fluorouracil (5-FU) 5% cream for SCCis found that shorter treatment duration (particularly under 2 weeks) and larger lesion size (> 2 cm) were associated with a higher risk for treatment failure. Beyond that, there was no [impact] of immunosuppression or anatomic location, including hair-bearing locations, on the risk of recurrence, Patel said. The patient decided to pursue 2 weeks of therapy with 5-FU to help mitigate potential side effects, Patel said after the meeting. 'He did well….and we decided to monitor after the shortened treatment course.' Is Intralesional Treatment Coming? In the future, intralesional treatment may make skin cancer therapy 'even easier' for older patients, Patel said at the meeting. In a case report published in 2024, a 98-year-old wheelchair-bound 80-pound woman with frailty — and a 3.5-cm rapidly growing crusted nodule on her left proximal-lateral arm was treated with intralesional 5-FU — weekly for 4 weeks — after a shave biopsy revealed an invasive, well-differentiated SCC. There was no sign of recurrence at 3 months, and the patient died 6 months later of primary cardiac arrest, Patel said, noting that this was a case 'of doing no harm and limiting the morbidity associated with this tumor rather than approaching it from an aggressive standpoint.' A phase 3 trial of intralesional cemiplimab in patients with early-stage cutaneous SCC, newly underway at GW and multiple other sites, will look at how well the immune checkpoint inhibitor works when injected into the lesion, compared with surgery. The goal is to provide cutting-edge immunotherapy while potentially avoiding systemic toxicity, thus making this a viable nonsurgical option for older patients or those with surgical fatigue, Patel said after the meeting. Patel disclosed that he had received consulting honoraria from Regeneron Pharmaceuticals, Sun Pharma, Almirall, and Palvella Therapeutics, as well as research support from Regeneron Pharmaceuticals. He had served on the speaker's bureau with Regeneron Pharmaceuticals, Sun Pharma, and Almirall, and was the cofounder of the Skin Cancer Outcomes Consortium. Lead image: Moment/Getty Images Image 1: GWU Department of Dermatology
Yahoo
an hour ago
- Yahoo
Multiple children rescued from South Mountain hiking trail amid extreme heat
Fire officials say five adults and six children started a hike on Holbert Trail around 10 a.m. About two hours into their hike, multiple children started to complain of heat and exhaustion and were unable to continue.
